Arca Biopharma | Ativo Circulante





Ativo Circulante Alterar Data
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amgen USD 29.06B 1.17B 2025-12
Arca Biopharma USD 355.16M 23.15M 2025-09
Biogen USD 8.97B 37.5M 2025-12
Brainstorm Cell Therapeutics USD 508K 1.01M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Capricor Therapeutics USD 100.95M 23.18M 2025-09
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 88.92M 8.72M 2025-09
CSL USD 11.85B 1000K 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Laboratory Of America USD 4.02B 58.3M 2025-12
Myriad Genetics USD 344.8M 60.5M 2025-09
Otsuka Holdings JPY 1.62T 113.12B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
United Therapeutics USD 3.7B 208.5M 2025-12


Arca Biopharma Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.